{"id":"NCT00899379","sponsor":"Organon and Co","briefTitle":"Treatment of Multiple Attacks of Acute Migraine (0462-025)","officialTitle":"A Randomized, Triple-Blind, Placebo-Controlled, Outpatient Study to Examine the Safety and Efficacy of MK462 10 mg p.o. in the Treatment of Multiple Attacks of Migraine Headache","status":"COMPLETED","phase":"PHASE3","dates":{"start":"1995-04","primaryCompletion":"1996-01","completion":"1996-04","firstPosted":"2009-05-12","resultsPosted":"2010-07-15","lastUpdate":"2022-02-03"},"enrollment":473,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Migraine Headache"],"interventions":[{"type":"DRUG","name":"rizatriptan benzoate","otherNames":["MK0462"]},{"type":"DRUG","name":"Comparator: Placebo","otherNames":[]}],"arms":[{"label":"Treatment Sequence 1","type":"EXPERIMENTAL"},{"label":"Treatment Sequence 2","type":"EXPERIMENTAL"},{"label":"Treatment Sequence 3","type":"EXPERIMENTAL"},{"label":"Treatment Sequence 4","type":"EXPERIMENTAL"},{"label":"Treatment Sequence 5","type":"EXPERIMENTAL"}],"summary":"A study to evaluate rizatriptan for the treatment of multiple attacks of acute migraine compared to placebo.","primaryOutcome":{"measure":"Pain Relief at 2 Hours During the First Migraine Attack Period","timeFrame":"2 hours","effectByArm":[{"arm":"Rizatriptan 10 mg","deltaMin":246,"sd":null},{"arm":"Placebo","deltaMin":30,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":9},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["19222588","19210513","9748025","11284464"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":337},"commonTop":["Dizziness","Somnolence","Nausea","Asthenia/Fatigue","Paresthesia"]}}